PNPLA6
Patatin-like phospholipase domain-containing protein 6
Also known as: iPLA2delta, NTE, PLPL6_HUMAN, SPG39, sws
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IY17
- Gene
- PNPLA6
- Ensembl
- ENSG00000032444
- Chromosome
- 19
- Canonical length
- 1375 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum,Cytosol
OverviewNCBI Gene
This gene encodes a phospholipase that deacetylates intracellular phosphatidylcholine to produce glycerophosphocholine. It is thought to function in neurite outgrowth and process elongation during neuronal differentiation. The protein is anchored to the cytoplasmic face of the endoplasmic reticulum in both neurons and non-neuronal cells. Mutations in this gene result in autosomal recessive spastic paraplegia, and the protein is the target for neurodegeneration induced by organophosphorus compounds and chemical warfare agents. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
1375 residues, UniProt reviewed canonical sequence.
>Q8IY17|PNPLA6
1 MEAPLQTGMM GTSSHGLATN SSGAKVAERD GFQDVLAPGE GSAGRICGAQ PVPFVPQVLG
61 VMIGAGVAVV VTAVLILLVV RRLRVPKTPA PDGPRYRFRK RDKVLFYGRK IMRKVSQSTS
121 SLVDTSVSAT SRPRMRKKLK MLNIAKKILR IQKETPTLQR KEPPPAVLEA DLTEGDLANS
181 HLPSEVLYML KNVRVLGHFE KPLFLELCRH MVFQRLGQGD YVFRPGQPDA SIYVVQDGLL
241 ELCLPGPDGK ECVVKEVVPG DSVNSLLSIL DVITGHQHPQ RTVSARAARD STVLRLPVEA
301 FSAVFTKYPE SLVRVVQIIM VRLQRVTFLA LHNYLGLTNE LFSHEIQPLR LFPSPGLPTR
361 TSPVRGSKRM VSTSATDEPR ETPGRPPDPT GAPLPGPTGD PVKPTSLETP SAPLLSRCVS
421 MPGDISGLQG GPRSDFDMAY ERGRISVSLQ EEASGGSLAA PARTPTQEPR EQPAGACEYS
481 YCEDESATGG CPFGPYQGRQ TSSIFEAAKQ ELAKLMRIED PSLLNSRVLL HHAKAGTIIA
541 RQGDQDVSLH FVLWGCLHVY QRMIDKAEDV CLFVAQPGEL VGQLAVLTGE PLIFTLRAQR
601 DCTFLRISKS DFYEIMRAQP SVVLSAAHTV AARMSPFVRQ MDFAIDWTAV EAGRALYRQG
661 DRSDCTYIVL NGRLRSVIQR GSGKKELVGE YGRGDLIGVV EALTRQPRAT TVHAVRDTEL
721 AKLPEGTLGH IKRRYPQVVT RLIHLLSQKI LGNLQQLQGP FPAGSGLGVP PHSELTNPAS
781 NLATVAILPV CAEVPMVAFT LELQHALQAI GPTLLLNSDI IRARLGASAL DSIQEFRLSG
841 WLAQQEDAHR IVLYQTDASL TPWTVRCLRQ ADCILIVGLG DQEPTLGQLE QMLENTAVRA
901 LKQLVLLHRE EGAGPTRTVE WLNMRSWCSG HLHLRCPRRL FSRRSPAKLH ELYEKVFSRR
961 ADRHSDFSRL ARVLTGNTIA LVLGGGGARG CSHIGVLKAL EEAGVPVDLV GGTSIGSFIG
1021 ALYAEERSAS RTKQRAREWA KSMTSVLEPV LDLTYPVTSM FTGSAFNRSI HRVFQDKQIE
1081 DLWLPYFNVT TDITASAMRV HKDGSLWRYV RASMTLSGYL PPLCDPKDGH LLMDGGYINN
1141 LPADIARSMG AKTVIAIDVG SQDETDLSTY GDSLSGWWLL WKRLNPWADK VKVPDMAEIQ
1201 SRLAYVSCVR QLEVVKSSSY CEYLRPPIDC FKTMDFGKFD QIYDVGYQYG KAVFGGWSRG
1261 NVIEKMLTDR RSTDLNESRR ADVLAFPSSG FTDLAEIVSR IEPPTSYVSD GCADGEESDC
1321 LTEYEEDAGP DCSRDEGGSP EGASPSTASE MEEEKSILRQ RRCLPQEPPG SATDALocalizationUniProt · AlphaFold · HPA
Whether an antibody against PNPLA6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 41 nTPM
Expression across tissuesHPA
Tissue
- spleen: 41 nTPM
- lung: 39 nTPM
- cerebral cortex: 37 nTPM
- testis: 35 nTPM
- skeletal muscle: 35 nTPM
- pituitary gland: 31 nTPM
Single-cell type
- late spermatids: 193 nCPM
- kupffer cells: 123 nCPM
- late primary spermatocytes: 109 nCPM
- oocytes: 97 nCPM
- early spermatids: 71 nCPM
- enterocytes: 67 nCPM
Immune cell
- eosinophil: 38 nTPM
- non-classical monocyte: 35 nTPM
- intermediate monocyte: 20 nTPM
- basophil: 16 nTPM
- myeloid DC: 12 nTPM
- classical monocyte: 11 nTPM
Brain region
- cerebral cortex: 122 nTPM
- thalamus: 108 nTPM
- pons: 108 nTPM
- medulla oblongata: 104 nTPM
- white matter: 100 nTPM
- midbrain: 99 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PNPLA6.
Disease | AllUniProt
Conditions PNPLA6 is implicated in, by any mechanism.
- Spastic paraplegia 39, autosomal recessive (SPG39) MIM:612020
- Boucher-Neuhauser syndrome (BNHS) MIM:215470
- Laurence-Moon syndrome (LNMS) MIM:245800
- Oliver-McFarlane syndrome (OMCS) MIM:275400
Disease | GeneticClinVar
123 pathogenic / likely-pathogenic of 1,521 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hereditary spastic paraplegia 39
- Ataxia-hypogonadism-choroidal dystrophy syndrome
- Trichomegaly-retina pigmentary degeneration-dwarfism syndrome
- Laurence-Moon syndrome
- PNPLA6-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0
- gnomAD missense Z
- 4.35
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- phosphatidylcholine lysophospholipase activity
- phospholipase B activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cyclic nucleotide-binding domain
- Patatin-like phospholipase domain
- RmlC-like jelly roll fold
- Acyl transferase/acyl hydrolase/lysophospholipase
- Cyclic nucleotide-binding domain superfamily
- Neuropathy target esterase
- Lysophospholipase NTE1-like, P-loop domain
- Cyclic nucleotide-binding domain
- Patatin-like phospholipase
- Neuropathy Target Esterase family P-loop like domain
- Lysophospholipase patatin, conserved site
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PNPLA6 as an antibody target. Whether an autoantibody or antibody against PNPLA6 could matter depends on whether native PNPLA6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PNPLA6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PNPLA6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...